Searched for
PIRAMAL PHARMA IPO
Piramal Pharma shares in focus after US FDA issues six observations for Mumbai facilityPiramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, resulting in a F...- Standard Glass IPO to hit markets next week; sets price band at Rs 133-140 per shareStandard Glass Lining Technology Ltd has set a price band of Rs 133-140 per share for its Rs 410.05 crore IPO. The subscription opens on Ja...
- Amansa Investment invests Rs 40 crore in Standard Glass Lining Technology IPO via private placementHyderabad-based Standard Glass Lining Technology, a manufacturer of specialized equipment for the pharmaceutical and chemical industries, r...
- Stock Radar: 170% rally in a year! Multibagger pharma stock breaks out from 6-week consolidation; time to buy?Piramal Pharma has broken out from a 6-week consolidation on weekly charts, now trading above key moving averages and is positioned to rise...
- 2 sectors Aditya Arora is bullish on for near termIf you look at the charts of Sharda Cropchem, then we have seen good upsurge today and stock has given breakout above levels of June 2023. ...
- 18 companies turned profitable in Q4 after 3 straight quarterly losses. Worth buying?18 companies including BHEL, Centrum Capital, Inox Wind, Piramal Pharma, SAMHI Hotels, and Sterling and Wilson turned profitable in Q4 afte...
- IndiaRF kicks off talks for $1 bn fundIndia Resurgence Fund (IndiaRF), a special situations investment platform sponsored by Piramal Enterprises and Bain Capital Credit, is in t...
- Piramal Pharma's Rs 1,050-cr rights issue gets Sebi's nodGoing by the draft papers, Piramal Pharma will issue fully paid-up equity shares of the company by way of a rights issue to its existing el...
- Looking for PSU bank exposure? Stick to SBI; rest are good for trade: Sandip Sabharwal“People who say that we should be buying any kind of stock at any valuations just because India will be in such a Goldilocks kind of scenar...
- Piramal Pharma to debut on bourses on WednesdayLast Thursday, the company said it has received Sebi’s go-ahead to list its equity shares on domestic stock exchanges
- RIL shares rise marginally ahead of 45th AGMDipan Mehta, Director at Elixir Equities, said there is always excitement around Reliance AGM, and one should expect some announcements, ev...
- Archean Chemical Industries files IPO papers with SebiThe IPO consists of a fresh issue of equity shares aggregating up to Rs 1,000 crore and an offer for sale of up to 1.9 crore shares by the ...
- ETMarkets After Hours: Matrimony IPO sails; pharma stocks on a highSensex gained 277 points to 32,159, with Tata Steel top gainer and Wipro the worst laggard.
- Pharma salesman’s company Eris Lifesciences eyes Rs 10,000-crore tag in IPOIndian pharma's first sales professional-turned-entrepreneur, the 41-year-old Amit Bakshi, has hired bankers for the IPO of Eris Lifescienc...
- Twelve stocks in focus in Wednesday morning tradeThe Indian market is expected to open higher. Here is a list of top twelve stocks that are likely to be in focus today.
- Cash rich Piramal set to invest Rs 1000 crore in road and renewable energy projectsThe road portfolio includes eight annuity and build-operate-transfer (BoT) projects with a total project cost of 8,700 crore.
- Pharmaceutical and healthcare sector to dominate M&As in 2012: Grant ThorntonIndia will see the largest number of M&As in pharmaceutical and healthcare sector this year despite regulations, according to Grant Thornto...
- Piramal Healthcare to buy 5.5% in Vodafone Essar for $640 millionPiramal Healthcare has agreed to buy 5.5% stake in Vodafone Essar, one of India's largest telecom companies, for $640 million.
- Ajay Piramal to exit real estate PE firmCompany In Talks With IL&FS , Blackstone & KKR For Buyout That May Be Valued At 600-650 Crore.
- Many deals didn’t meet our investment criteria: Chrys CapitalIn conversation with ET , Mr Kaul, managing director, ChrysCapital discusses the changing landscape of Indian pharma and the firm’s investm...
Load More
